Contact Us
Contact Us

Media Library

10 Dec 2024
Q&A with hVIVO’s Mo Khan
10 Dec 2024
hVIVO signs £11.5M RSV trial contract; expands services at new facility
03 Dec 2024
VaccineNation Interview with Adam French - WVC EU 2024
26 Nov 2024
VaccineNation Interview with Andrew Catchpole - WVC EU 2024
22 Oct 2024
hVIVO's Senior Director of Patient Enrolment & Retention on Canary Wharf Facility

Categories:

Video Categories
  • Interview
  • Investors
  • Scientific
  • Corporate
  • Presentation
  • Podcast

Year:

Filter by Year

10 Dec 2024

hVIVO signs £11.5M RSV trial contract; expands services at new facility
Watch

10 Dec 2024

Q&A with hVIVO’s Mo Khan
Watch

03 Dec 2024

VaccineNation Interview with Adam French - WVC EU 2024
Watch

26 Nov 2024

VaccineNation Interview with Andrew Catchpole - WVC EU 2024
Watch

22 Oct 2024

hVIVO's Senior Director of Patient Enrolment & Retention on Canary Wharf Facility
Watch

10 Oct 2024

hVIVO's Head of QA on the State-of-the-Art facility at Canary Wharf
Watch

08 Oct 2024

Growing your business in a challenging marketplace: a CEO perspective

12 Sep 2024

hVIVO PLC - Interim Results, September 2024
Watch

10 Sep 2024

hVIVO CEO discusses record H1 revenue and strategic expansion
Watch

10 Sep 2024

Interview with CEO Mo Khan, of hVIVO
Watch

04 Sep 2024

Describing the World's Largest Human Challenge Unit
Watch

29 Aug 2024

Andrew Catchpole on Human Challenge Trials & Canary Wharf State-of-the-Art facility
Watch

22 Aug 2024

Director of Clinical Operations on hVIVO's State-of-the-Art Facility in Canary Wharf
Watch

15 Aug 2024

hVIVO at Canary Wharf - Yamin 'Mo' Khan
Watch

12 Aug 2024

Capital Markets Day 2024
Watch

05 Aug 2024

Opening of the World’s Largest Human Challenge Trial Unit
Watch

18 Jul 2024

Canary Wharf Facilities Walk Through Tour
Watch

18 Jul 2024

Timeline Video hVIVO
Watch

17 Jul 2024

hVIVO achieves record first-half revenue as it expands with new Canary Whart headquarters
Watch

17 Jul 2024

Q&A with hVIVO’s Mo Khan
Watch

17 Jul 2024

Capital Markets Day 2024

09 Jul 2024

hVIVO Joining the Life Science Hub at Canary Wharf
Watch

03 Jul 2024

hVIVO CEO Mo Khan on company's expansion and upcoming capital markets day
Watch

12 Jun 2024

Dr Andrew Catchpole on Omicron BA.5 Characterisation Study
Watch

03 Jun 2024

Hvivo Q&A: “this contract is important as it opens up new markets”
Watch

03 Jun 2024

hVIVO secures £2.5mln contract for Omicron characterisation study
Watch

09 May 2024

WVC Washington: Interview with hVIVO's Dr Andrew Catchpole
Watch

09 Apr 2024

hVIVO achieves record revenue and initiates dividend policy following successful year
Watch

09 Apr 2024

Hvivo results Q&A with CEO Mo Khan: “we are very confident we will get to £100m of revenue in 2028”
Watch

09 Apr 2024

Full Year Results 2023
Watch

13 Mar 2024

Yamin ‘Mo’ Khan, CEO of hVIVO, presents at the UK Investor Magazine Investor Conference at the London Stock Exchange
Watch

19 Feb 2024

hVIVO chairman Cathal Friel says he remains committed to hVIVO following share sale
Watch

30 Jan 2024

Q&A with hVIVO’s Mo Khan: “£80 million is the highest starting order book in the history of the company"

30 Jan 2024

hVIVO announces record financial performance for 2023; projects strong future growth
Watch

30 Jan 2024

hVIVO PLC - Company Presentation
Watch

02 Jan 2024

hVIVO secures £6.3 million challenge contract
Watch

28 Dec 2023

Year in Review 2023
Watch

28 Dec 2023

Ask the Experts: A Deep Dive into Human Challenge Trials
Watch

21 Dec 2023

hVIVO year in review: bigger and better

13 Dec 2023

Q&A: hVivo’s Mo Khan on the company’s latest mega-deal
Watch

13 Dec 2023

hVIVO secures fresh contract to round out "wonderful" year
Watch

25 Sep 2023

Master Investor Sector Focus: Healthcare
Watch

20 Sep 2023

hVIVO Canary Wharf Facilities - Adam French
Watch

13 Sep 2023

hVIVO PLC - Interim Results Presentation
Watch

12 Sep 2023

hVIVO has "the perfect opportunity" after strong first half
Watch

12 Sep 2023

Q&A with hVIVO’s Mo Khan
Watch

29 Aug 2023

hVIVO announces move to "good facility at a very good price"
Watch

29 Aug 2023

Plans for a new larger state-of-the-art facility in Canary Wharf
Watch

31 Jul 2023

Developing an Influenza B Human Challenge Model
Watch

26 Jul 2023

hVIVO CEO reports on "very strong" H1 2023
Watch

26 Jul 2023

hVIVO’s Mo Khan: “We have now got 100% contracted work this year to hit our revenue targets”
Watch

26 Jul 2023

hVIVO plc – Trading update H1 2023
Watch

25 Jul 2023

hVIVO signs second bespoke human challenge model contract in as many months
Watch

25 Jul 2023

hVIVO’s Mo Khan: “the industry is really waking up to the value of human challenge models"
Watch

10 Jul 2023

hVIVO targeting the nasty virus no one has heard of
Watch

29 Jun 2023

hVIVO to Develop hMPV Human Challenge Model
Watch

28 Jun 2023

hVIVO to develop first commercial hMPV human challenge model
Watch

15 May 2023

Topra Webinar - Human Challenge Trials: Supporting the development of ‘next generation’ COVID-19 Vaccines
Watch

15 May 2023

Tom Scott: The people who get paid to get sick
Watch

25 Apr 2023

hVIVO reveals audited results for "transformational" 2022
Watch

25 Apr 2023

'Mo' Khan of Hvivo: 2022 was a transformative and order book gives strong visibility into H1 2024

25 Apr 2023

Full Year Results 2022
Watch

14 Apr 2023

hVIVO at World Vaccine Congress Washington 2023
Watch

02 Mar 2023

hVIVO’s Andrew Catchpole Talks Human Challenge Trials, From COVID-19 to Malaria

06 Feb 2023

hVIVO Asian growth strategy bearing fruit with second 2023 contract win
Watch

25 Jan 2023

hVIVO PLC - Investor Presentation
Watch

15 Jan 2023

hVIVO announces "record results" for 2022
Watch

15 Jan 2023

hVIVO's Mo Khan on the company’s breakthrough year

05 Jan 2023

hVIVO CEO Mo Khan discusses the company's Asia Pacific breakthrough

04 Jan 2023

hVIVO contract the fruit of increasing Asian focus
Watch

03 Jan 2023

Year in Review 2022 - hVIVO Group
Watch

10 Nov 2022

hVIVO hails growing contract values after winning £13.6mln RSV challenge trial deal
Watch

02 Nov 2022

Capital Markets Day 2022

08 Sep 2022

Open Orphan's CEO talks through name change and a first half 'full of highlights'
Watch

08 Sep 2022

OPEN ORPHAN PLC - 2022 Interim Results - Investor presentation
Watch

05 Aug 2022

£6.2m Influenza human challenge study contract - BRR Media
Watch

04 Aug 2022

Open Orphan subsidiary hVIVO wins £6.2m Influenza human challenge study contract with US customer
Watch

01 Jul 2022

Open Orphan and Vaxart are preparing a world-first human challenge model for omicron oral vaccine
Watch

15 Jun 2022

LSX World Congress 2022
Watch

14 Jun 2022

hVIVO’s £7.2m RSV Human Challenge Model Contract
Watch

07 Jun 2022

Open Orphan’s Yamin Khan talks through its ‘excellent’ results
Watch

01 Jun 2022

Open Orphan racks up another ‘first’ with £14.7mln full-service flu contract
Watch

19 May 2022

Chief Scientific Officer on Influenza Challenge Study contract Win
Watch

09 Mar 2022

London South East Presentation March 2022
Watch

08 Mar 2022

Volunteer Recruitment & Laboratory Facilities Expansion – Robin Rogiers & BRR Media
Watch

08 Mar 2022

Open Orphan sticks to 2021 earnings guidance as it announces an expansion of its facilities
Watch

24 Feb 2022

Open Orphan announce Yamin ‘Mo’ Khan as new CEO
Watch

24 Feb 2022

CEO Appointment at Open Orphan
Watch

17 Feb 2022

hVIVO hail data on phase 2a study published in New England Journal of Medicine
Watch

14 Feb 2022

Adrian Wildfire on hVIVO STRiVE Project
Watch

14 Feb 2022

Open Orphan subsidiary hVIVO launch of STRiVE to ‘find out what people are actually suffering from’
Watch

02 Feb 2022

CSO Andrew Catchpole on the world’s first COVID-19 Characterisation Study
Watch

02 Feb 2022

Open Orphan present ‘invaluable’ key findings of world’s first COVID-19 characterisation study
Watch

02 Feb 2022

Open Orphan’s Cathal Friel presents results from world’s first COVID-19 characterisation study
Watch

24 Jan 2022

hVIVO Malaria Challenge Agent
Watch

24 Jan 2022

Executive Chairman Cathal Friel on The world’s first COVID-19 Characterisation Study
Watch

20 Jan 2022

Cathal Friel on Malaria Human Challenge Agent
Watch

21 Dec 2021

Open Orphan hail £5m contract for new flu jab challenge study
Watch

24 Aug 2021

Cathal Friel and BRR Media Discuss £8.1m Asthma Human Challenge Study Contract Win
Watch

20 Jul 2021

Open Orphan announce ‘substantial contract wins’ with an existing client and UK government
Watch

07 Jun 2021

FluCamp Hotel Quarantine Facility – Bedroom Tour
Watch

09 Apr 2021

Open Orphan: Global Leader in Human Challenge Vaccine Development | Executive Chairman Cathal Friel
Watch

16 Dec 2020

Shares Investor Evening with Cathal Friel December 2020
Watch

16 Dec 2020

hVIVO secure MHRA approval to start Codagenix COVID-19 Phase I Vaccine Trial
Watch

07 Dec 2020

Open Orphan 2020 Year in Review
Watch

20 Nov 2020

COVID-19: UK scientists to infect volunteers with coronavirus in world first vaccine trial
Watch

20 Oct 2020

Market Coverage: Tuesday October 20 Yahoo Finance
Watch

20 Oct 2020

Young people to be deliberately exposed to Covid-19 to speed up vaccine development
Watch

06 Oct 2020

Open Orphan Dual Business Firing on All Four Cylinders
Watch

06 Oct 2020

Shares Magazine Investor Evening October 2020
Watch

01 Oct 2020

Open Orphan Interim Results Interview 2020
Watch

10 Aug 2020

Interview with Proactive Investors following £4M contract with Top 3 Global Pharma company
Watch

08 Jun 2020

Coronavirus: I took a COVID-19 antibody test to see if I’d had coronavirus without realising it
Watch

11 May 2015

FluCamp – what it is like to participate in a clinical trial
Watch

15 Sep 2014

hVIVO on BBC1 2014
Watch
chevron-downarrow-upcross-circle